Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 25,118 | 10,734 | 6,161 | 143 | 1,031 |
| Cost of Goods | 154 | 200 | N/A | N/A | N/A |
| Gross Profit | 24,964 | 10,534 | 5,085 | 143 | 1,031 |
| Operating Expenses | 157,577 | 151,112 | 139,827 | 142,729 | 130,143 |
| Operating Income | -132,459 | -140,378 | -133,666 | -142,586 | -129,112 |
| Other Income | 11,604 | 12,533 | 11,031 | 12,495 | 13,475 |
| Pre-tax Income | -120,855 | -127,845 | -122,635 | -130,091 | -115,637 |
| Net Income Continuous | -120,855 | -127,845 | -122,815 | -130,091 | -115,637 |
| Net Income | $-120,855 | $-127,845 | $-122,815 | $-130,091 | $-115,637 |
| EPS Basic Total Ops | -1.14 | -1.23 | -1.30 | -1.38 | -1.23 |
| EPS Basic Continuous Ops | -1.14 | -1.23 | -1.29 | -1.38 | -1.23 |
| EPS Diluted Total Ops | -1.14 | -1.23 | -1.30 | -1.38 | -1.23 |
| EPS Diluted Continuous Ops | -1.14 | -1.23 | -1.29 | -1.38 | -1.23 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.23 | -1.29 | -1.38 | -1.23 |
| EBITDA(a) | $-133,409 | $-141,438 | $-135,406 | $-145,175 | $-132,867 |